- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of multiple sclerosis in children and adolescents
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 11, Issue 4, Pages 505-520
Publisher
Informa Healthcare
Online
2010-02-18
DOI
10.1517/14656560903527218
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis
- (2009) Bibiana Bielekova et al. ARCHIVES OF NEUROLOGY
- Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis
- (2009) Mark P. Gorman et al. ARCHIVES OF NEUROLOGY
- Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: a retrospective study
- (2009) Emilia Sbardella et al. BMC Neurology
- FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
- (2009) Volker Brinkmann BRITISH JOURNAL OF PHARMACOLOGY
- Pediatric multiple sclerosis
- (2009) Emmanuelle Waubant et al. Current Treatment Options in Neurology
- Monoclonal antibody treatments for multiple sclerosis
- (2009) John W. Rose et al. Current Treatment Options in Neurology
- ‘Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis’
- (2009) Michael Karenfort et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study
- (2009) A. B. Oturai et al. EUROPEAN JOURNAL OF NEUROLOGY
- Oral laquinimod therapy in relapsing multiple sclerosis
- (2009) Jana Preiningerova EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Sustained-release fampridine for multiple sclerosis
- (2009) Christopher T Bever et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Sustained release oral fampridine in the treatment of multiple sclerosis
- (2009) Norman J Kachuck EXPERT OPINION ON PHARMACOTHERAPY
- Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
- (2009) G Comi et al. LANCET
- Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
- (2009) Andrew D Goodman et al. LANCET
- Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis
- (2009) Richard A Rudick et al. LANCET NEUROLOGY
- Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required
- (2009) Ana M Pascual et al. Multiple Sclerosis Journal
- Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis
- (2009) E Havrdova et al. Multiple Sclerosis Journal
- Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States
- (2009) T Chitnis et al. Multiple Sclerosis Journal
- New oral drugs for multiple sclerosis
- (2009) Claudio Gasperini et al. NEUROLOGICAL SCIENCES
- Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience
- (2009) Angelo Ghezzi et al. NEUROLOGICAL SCIENCES
- Sensitivity vs specificity: Progress and pitfalls in defining MRI criteria for pediatric MS
- (2009) T. Chitnis et al. NEUROLOGY
- Cyclophosphamide therapy in pediatric multiple sclerosis
- (2009) N. Makhani et al. NEUROLOGY
- Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS
- (2009) J. A. Cohen et al. NEUROLOGY
- Natalizumab Use in Pediatric Multiple Sclerosis
- (2008) Peter Huppke et al. ARCHIVES OF NEUROLOGY
- Effectiveness of early beta interferon on the first attack after confirmed multiple sclerosis: A comparative cohort study
- (2008) Yann Mikaeloff et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Natalizumab treatment in pediatric multiple sclerosis: A case report
- (2008) Giovanna Borriello et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Combination therapies in multiple sclerosis
- (2008) Ralf Gold JOURNAL OF NEUROLOGY
- Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations
- (2008) et al. JOURNAL OF NEUROLOGY
- New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab
- (2008) Hans-Peter Hartung LANCET NEUROLOGY
- Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study
- (2008) E Cocco et al. Multiple Sclerosis Journal
- Vanishing MS T2-bright lesions before puberty: A distinct MRI phenotype?
- (2008) D. Chabas et al. NEUROLOGY
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: An open-label comparative study of efficacy and safety
- (2007) Valentina Zipoli et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now